This AI trading robot, accessible at Swing Trader: High Volatility Stocks for Active Trading (TA&FA), was one of the best in our robot factory, generating a 5.80% gain for BNGO over the course of the previous month.
One of the indicators that this robot uses is the Moving Average Convergence Divergence (MACD). For BNGO, the MACD turned positive on March 27, 2023. This is a bullish signal that indicates the stock is likely to continue rising. In fact, looking at past instances where BNGO's MACD turned positive, the stock continued to rise in 36 of 40 cases over the following month. This puts the odds of a continued upward trend at an impressive 90%.
With the help of AI trading robots like the one at Swing Trader: High Volatility Stocks for Active Trading (TA&FA), investors can benefit from the power of data analysis and automation to make better trading decisions. By using technical indicators like the MACD, these robots can help investors identify potential opportunities and manage risk more effectively. It is important, however, to remember that no trading strategy or robot is infallible, and investors should always conduct their own research and analysis before making any trading decisions.
The RSI Oscillator for BNGO moved out of oversold territory on May 03, 2023. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 39 similar instances when the indicator left oversold territory. In of the 39 cases the stock moved higher. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on May 30, 2023. You may want to consider a long position or call options on BNGO as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BNGO just turned positive on May 05, 2023. Looking at past instances where BNGO's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BNGO advanced for three days, in of 191 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 120 cases where BNGO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 35 cases where BNGO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BNGO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BNGO broke above its upper Bollinger Band on June 01, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.979) is normal, around the industry mean (28.921). P/E Ratio (0.000) is within average values for comparable stocks, (142.211). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.647). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (7.348) is also within normal values, averaging (57.088).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BNGO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BNGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of technologies for analysis of large biological molecules
A.I.dvisor indicates that over the last year, BNGO has been loosely correlated with PACB. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if BNGO jumps, then PACB could also see price increases.
|PACB - BNGO|
|ME - BNGO|
|ESTA - BNGO|
|TWST - BNGO|
|ALGN - BNGO|